|
⚲
|
| Keyboard |
| Eliem Therapeutics Inc | |
|---|---|
| Ticker | CLYM |
| CIK # | 0001768446 |
| CUSIP | 28658R106 |
| Sector | Life Sciences - Pharmaceutical Preparations |
| Address | 23515 NE Novelty Hill Road Suite B221 #125, Redmond, WA 98053 |
| Source | [EDGAR] |
| Reg D Offering (Form D) | Filed | Raised | Terms |
|---|---|---|---|
| Eliem Therapeutics Inc | 2024-07-02 | 120.0 M | Exemption: 506(b) · Duration: One year or less · Revenue: Decline to Disclose |
| CIK | Filing | 2011 - 2026 |
|---|---|---|
| [0001768446] | 10-K | |
| [0001768446] | 10-Q | |
| [0001768446] | 3 | |
| [0001768446] | 4 | |
| [0001768446] | 8-K | |
| [0001768446] | D | |
| [0001768446] | SC 13D | |
| [0001768446] | SC 13G |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed | % Owned |
|---|---|---|---|
| FMR LLC | Climb Bio Inc | [2026-07-08] | 0.0 |
| MPM Bioimpact LLC | Climb Bio Inc | [2026-02-17] | 0.0 |
| Deep Track Capital LP | Eliem Therapeutics Inc | [2024-07-02] | 5.85 |
| Affinity Asset Advisors LLC | Eliem Therapeutics Inc | [2024-05-07] | 6.02 |
| ICG Life Sciences SCSP | Eliem Therapeutics Inc | [2022-09-22] | 7.5 |
| BML Investment Partners LP | Eliem Therapeutics Inc | [2022-05-04] | 6.5 |
| Samlyn Capital LLC | Eliem Therapeutics Inc | [2022-02-14] | 6.4 |
| AI ETI LLC | Eliem Therapeutics Inc | [2021-08-23] | 19.8 |
| RA Capital Management LP | Eliem Therapeutics Inc | [2021-08-19] | 50.0 |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Thomas Stephen Basil
Common Stock
|
2026-02-26 | Sell | 16,313 | $7.01 | 114,354 |
|
Thomas Stephen Basil
Common Stock
|
2026-02-25 | Sell | 33,687 | $7.00 | 235,809 |
|
Thomas Stephen Basil
Common Stock
|
2026-02-13 | Sell | 10,000 | $5.81 | 58,100 |
|
Thomas Stephen Basil
Common Stock
|
2026-02-12 | Sell | 90,000 | $5.23 | 470,700 |
|
Brennan Aoife
Stock Option (Right to Buy) · derivative
|
2026-01-06 | Grant | 700,000 | $0.00 | |
|
ALTSCHULLER Susan
Stock Option (Right to Buy) · derivative
|
2026-01-06 | Grant | 142,500 | $0.00 | |
|
Driscoll Cindy
Stock Option (Right to Buy) · derivative
|
2026-01-06 | Grant | 100,000 | $0.00 | |
|
Wilson Perrin Megan
Stock Option (Right to Buy) · derivative
|
2026-01-06 | Grant | 300,000 | $0.00 | |
|
Kolchinsky Peter +6
Common Stock
|
2026-01-05 | Buy | 7,111 | $3.50 | 24,888 |
|
Kolchinsky Peter +6
Common Stock
|
2025-12-12 | Buy | 101,462 | $2.86 | 290,181 |
|
Kolchinsky Peter +6
Pre-Funded Warrants (Right to Buy) · derivative
|
2025-12-11 | Grant | 20,440,000 | ||
|
Kolchinsky Peter +6
Common Stock
|
2025-12-11 | Buy | 213,099 | $2.18 | 464,556 |
|
Kolchinsky Peter +6
Common Stock
|
2025-12-11 | Disposed to issuer | 20,440,000 | $0.00 | |
|
ALTSCHULLER Susan
Stock Option (Right to Buy) · derivative
|
2025-10-01 | Grant | 600,000 | $0.00 | |
|
Thomas Stephen Basil
Common Stock
|
2025-08-07 | Grant | 100,375 | $0.00 | |
|
Brennan Aoife
Common Stock
|
2025-06-30 | Sell | 20,618 | $1.22 | 25,154 |
|
Thomas Stephen Basil
Restricted Stock Units · derivative
|
2025-06-27 | Option exercise | 25,094 | $0.00 | |
|
Brennan Aoife
Restricted Stock Units · derivative
|
2025-06-27 | Option exercise | 68,750 | $0.00 | |
|
Brennan Aoife
Common Stock
|
2025-06-27 | Option exercise | 68,750 | ||
|
Thomas Stephen Basil
Common Stock
|
2025-06-27 | Option exercise | 25,094 | ||
| showing 20 of 144 most recent transactions | |||||
| 13F Ownership Over Time | Holders | Shares Held |
|---|---|---|
| 2026-03-31 | 80 | 30,423,412 |
| 2025-12-31 | 65 | 29,327,193 |
| 2025-09-30 | 68 | 44,658,249 |
| 2025-06-30 | 69 | 49,883,812 |
| 2025-03-31 | 77 | 51,939,065 |
| 2024-12-31 | 81 | 55,706,682 |
| 2024-09-30 | 72 | 54,676,977 |
| 2024-06-30 | 48 | 49,913,169 |
| 2024-03-31 | 22 | 16,858,868 |
| 2023-12-31 | 24 | 16,855,470 |
| 2023-09-30 | 24 | 16,728,646 |
| 2023-06-30 | 23 | 16,730,486 |
| Form 13F Holdings | ||||
|---|---|---|---|---|
| Firm | Period | DFND | Voting | Shares |
| Farther Finance Advisors LLC | [2026-06-30] | SOLE | 0 | 821 |
| Fortitude Family Office LLC | [2026-06-30] | SOLE | 92 | 92 | Prev | Page 1 | Next |